The aim of this retrospective study was to examine the influence of HER2 status on outcome in breast cancer patients following whole brain radiotherapy (WBRT) for cerebral metastases. One hundred and eighty one patients with recordable HER2 status, who received WBRT at single institution were identified and stratified according to HER2 status. Eighty eight were HER2 positive (HER2+) (49%) and 93 HER2 negative (HER2-) (51%). A total of 72 (82%) HER2+ group developed brain metastases whilst on ...Expand abstract
- Publisher copy:
- Copyright date:
- PubMed ID: 18571923
HER2 significance and treatment outcomes after radiotherapy for brain metastases in breast cancer patients.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record